Pizzorno, G

Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM. [electronic resource] - Cancer research Feb 1995 - 566-73 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0008-5472


5,10-Methylenetetrahydrofolate Reductase (FADH2)
Acyltransferases--antagonists & inhibitors
Antineoplastic Agents--pharmacology
Clone Cells
Drug Resistance
Folic Acid Antagonists--pharmacology
Formate-Tetrahydrofolate Ligase--metabolism
Glycine Hydroxymethyltransferase--metabolism
Humans
Hydroxymethyl and Formyl Transferases
Leukemia, Lymphoid
Methylenetetrahydrofolate Dehydrogenase (NADP)--metabolism
Methylenetetrahydrofolate Reductase (NADPH2)
Oxidoreductases--metabolism
Peptide Synthases--metabolism
Phosphoribosylaminoimidazolecarboxamide Formyltransferase
Phosphoribosylglycinamide Formyltransferase
Stereoisomerism
Tetrahydrofolate Dehydrogenase--metabolism
Tetrahydrofolates--pharmacology
Thymidylate Synthase--metabolism
Tumor Cells, Cultured
gamma-Glutamyl Hydrolase--metabolism